PROKIDNEY CORP. — Director's Dealing 2023

Jul 13, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PROKIDNEY CORP. (PROK)
CIK: 0001850270
Period of Report: 2023-07-12

Reporting Person: Fox Jennifer A. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-07-12	Director stock option (right to buy)	$10.92	A	46632	Acquired	2033-07-12	Class A Ordinary Shares (46632)	Direct
2023-07-12	Director stock option (right to buy)	$10.92	A	42515	Acquired	2033-07-12	Class A Ordinary Shares (42515)	Direct

Footnotes

F1: The options will vest in full on the sooner of the one-year anniversary of the date of grant or the date of Company's next annual general shareholder meeting subject to Ms. Fox's continued service with the Company through the applicable vesting date.

F2: The option shall vest and become exercisable in two equal annual installments on July 11, 2024 and July 11, 2025 subject to Ms. Fox's continued service with the Company through the applicable vesting date.